Vorinostat in glioblastoma multiforme (Gbm): updated results from phase I and II trials provide the rationale for further clinical development.
- Citation:
- Ann Oncol vol 19 (Suppl 8) 249-250 abstr 806PD
- Meeting Instance:
- ESMO 2008
- Year:
- 2008
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 284
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- E. Galanis K. Jaeckle J. Buckner M. Maurer J. Hardwick V. Puduvalli K. Lamborn J. Kuhn M. Prados P. Wen
- Networks:
- Study
- NCCTG-N047B
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: